PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Detalles Bibliográficos
Autores principales: Pinczes, L. I., Magyari, F., Páyer, E., Farkas, K., Ujfalusi, S., Diószegi, Á., Deme, A., Sik, M., Nagy, G., Hevessy, Z., Nagy, B., Illés, Á.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431478/
http://dx.doi.org/10.1097/01.HS9.0000851932.19116.3c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431478/
http://dx.doi.org/10.1097/01.HS9.0000851932.19116.3c

Ejemplares similares